Annabel McMillan

10PUBLICATIONS
33CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMedical mycologyHaematologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 04, 2025
Assessment and treatment of frail patients living with multiple myeloma. A guideline on behalf of the UK Myeloma Research Alliance Frailty Group.

Sally Moore, Hannah Miller, Christopher Parrish

|Oct 17, 2024
Myeloid neoplasm post cytotoxic treatment in patients with multiple myeloma.

Ke Xu, Eleanor Kaffo, Robert Baker

|Oct 17, 2024
Outcomes of melphalan 140 mg/m2 followed by autologous stem cell transplantation in multiple myeloma patients with co-morbidities: Single-centre experience.

Dario Melotti, Samir Asher, Ethan Troy-Barnes

|Jul 24, 2023
Haematopoietic stem cell mobilisation followed by high-dose chemotherapy and autologous stem cell transplantation for patients with sickle cell disease and myeloma.

S Asher, R Shah, S Ings

|Feb 23, 2023
Daratumumab, bortezomib and dexamethasone at first relapse for patients with multiple myeloma: A real-world multicentre UK retrospective analysis.

Annabel McMillan, Supratik Basu, Kamaraj Karunanithi

|Nov 12, 2022
Adaptation of a multiple myeloma minimal residual disease multicolor flow cytometry assay for real-world practice.

Annabel McMillan, Thien-An Tran, Daria Galas-Filipowicz

Pageof 2

Frequent Collaborators

4 joint publications

Ke Xu

3 joint publications

Kwee Yong

2 joint publications

Samir Asher

2 joint publications

George Nesr